155 related articles for article (PubMed ID: 22471392)
1. Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome - a randomised, double-blind, crossover trial.
Williams A; Kenny D; Wilson D; Fagenello G; Nelson M; Dunstan F; Cockcroft J; Stuart G; Fraser AG
Eur J Clin Invest; 2012 Aug; 42(8):891-9. PubMed ID: 22471392
[TBL] [Abstract][Full Text] [Related]
2. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
Ahimastos AA; Aggarwal A; D'Orsa KM; Formosa MF; White AJ; Savarirayan R; Dart AM; Kingwell BA
JAMA; 2007 Oct; 298(13):1539-47. PubMed ID: 17911499
[TBL] [Abstract][Full Text] [Related]
3. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
Pannier BM; Guerin AP; Marchais SJ; London GM
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1074-7. PubMed ID: 11903319
[TBL] [Abstract][Full Text] [Related]
4. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
Ruilope LM; Schaefer A
Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
[TBL] [Abstract][Full Text] [Related]
6. A double blind comparison of perindopril and atenolol in essential hypertension.
Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
Asmar RG; London GM; O'Rourke ME; Mallion JM; Romero R; Rahn KH; Trimarco B; Fitzgerald D; Hedner T; Duprez D; De Leeuw PW; Sever P; Battegay E; Hitzenberger G; de Luca N; Polónia P; Bénétos A; Chastang C; Ollivier JP; Safar ME;
J Hypertens Suppl; 2001 Nov; 19(4):S15-20. PubMed ID: 11848258
[TBL] [Abstract][Full Text] [Related]
10. Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement.
Meijboom LJ; Westerhof BE; Nollen GJ; Spaan JA; de Mol BA; Jacobs MJ; Mulder BJ
Eur J Cardiothorac Surg; 2004 Nov; 26(5):901-6. PubMed ID: 15519180
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Williams B; Lacy PS; Thom SM; Cruickshank K; Stanton A; Collier D; Hughes AD; Thurston H; O'Rourke M; ; ;
Circulation; 2006 Mar; 113(9):1213-25. PubMed ID: 16476843
[TBL] [Abstract][Full Text] [Related]
12. Do losartan and atenolol have differential effects on BNP and central haemodynamic parameters?
Davies J; Carr E; Band M; Morris A; Struthers A
J Renin Angiotensin Aldosterone Syst; 2005 Dec; 6(3):151-3. PubMed ID: 16525946
[TBL] [Abstract][Full Text] [Related]
13. Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome.
Bhatt AB; Buck JS; Zuflacht JP; Milian J; Kadivar S; Gauvreau K; Singh MN; Creager MA
Vasc Med; 2015 Aug; 20(4):317-25. PubMed ID: 25795452
[TBL] [Abstract][Full Text] [Related]
14. Perindopril, atenolol, and amlodipine prevent aortic ultrastructural changes in rats exposed to ethanol.
Yokusoglu M; Sag C; Cincik M; Uzun M; Kayir H; Koz C; Baykal B; Ozkan M; Ozogul C; Baysan O; Uzbay IT
Med Sci Monit; 2008 May; 14(5):BR96-102. PubMed ID: 18443544
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
16. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Dhakam Z; McEniery CM; Yasmin ; Cockcroft JR; Brown MJ; Wilkinson IB
Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
[TBL] [Abstract][Full Text] [Related]
17. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.
Armentano RL; Graf S; Ramírez AJ; Espinosa JD; Brandani L; Baglivo H; Sánchez R
Medicina (B Aires); 2001; 61(5 Pt 1):535-40. PubMed ID: 11721319
[TBL] [Abstract][Full Text] [Related]
18. Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect.
Watanabe Y; Takasugi E; Shitakura K; Okajima K; Hota N; Kubo Y; Nunoda S; Otsuka K
Clin Exp Hypertens; 2011; 33(4):246-54. PubMed ID: 21699451
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.
Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C
Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809
[TBL] [Abstract][Full Text] [Related]
20. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H
Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]